Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454560 | SCV000540451 | uncertain significance | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in individuals with Kallman syndrome and controls was the same (Miraoui 2013). |
Labcorp Genetics |
RCV000954651 | SCV001101297 | likely benign | not provided | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000954651 | SCV001820344 | likely benign | not provided | 2020-08-26 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31726455, 23643382) |
Ce |
RCV000954651 | SCV004157259 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | SPRY4: BS2 |
OMIM | RCV000043616 | SCV000071634 | risk factor | Hypogonadotropic hypogonadism 17 with or without anosmia | 2013-05-02 | no assertion criteria provided | literature only | |
Yale Center for Mendelian Genomics, |
RCV001849295 | SCV002106771 | uncertain significance | Amenorrhea | 2021-03-08 | no assertion criteria provided | literature only |